Impact of gender differences on the outcome of Alzheimer's disease.
OBJECTIVE
Since little is known about the role of gender in the course of Alzheimer's disease (AD), a prospective epidemiological study was conducted to detect gender differences in relation to AD evolution and outcome.


METHODS
Six hundred AD patients, 214 men and 386 women, first seen between September 2000 and December 2003, were enrolled; the follow-up period lasted until December 2008.


RESULTS
The men had greater comorbidity and higher mortality than the women, who instead recorded more disability and longer survival. Survival curves showed that women reach partial loss of autonomy faster than men. Higher Neuropsychiatric Inventory scores at baseline showed a predictive value for loss of autonomy regardless of gender. Pharmacological treatment seems to have a protective role on disability and mortality.


CONCLUSIONS
Gender influences disease evolution not only directly but also through other factors such as comorbidity.
Sinforiani
E
E
IRCCS C. Mondino Foundation, National Institute of Neurology, Pavia, Italy. elena.sinforiani@mondino.it
Citterio
A
A
Zucchella
C
C
Bono
G
G
Corbetta
S
S
Merlo
P
P
Mauri
M
M
D000203:Activities of Daily Living / Q000523:psychology; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005260:Female; D016330:Frail Elderly / Q000523:psychology; D006801:Humans; D007361:Intelligence Tests; D007558:Italy; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012737:Sex Factors; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors